Home > Healthcare > Healthcare IT > Health Services > treatment planning systems and advanced image processing market
Get a free sample of Treatment Planning Systems and Advanced Image Processing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Treatment Planning Systems and Advanced Image Processing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Treatment Planning Systems and Advanced Image Processing Market size was valued at around USD 2 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032. Treatment planning systems are software platforms designed to create precise and individualized treatment plans for patients undergoing radiation therapy. Advanced image processing refers to the use of sophisticated algorithms and software to enhance, analyze, and interpret medical images.
The increasing incidence of cancer and the growing number of medical imaging procedures are driving the demand for treatment planning systems, which is anticipated to boost market growth over the forecast period. Furthermore, the global expansion of the market is being driven by the need for precise and innovative oncology treatments through the utilization of advanced image processing technology. Additionally, the development of healthcare IT infrastructure and the heightened implementation of machine learning (ML) and artificial intelligence (AI) in oncology are contributing to the market's growth.
The increasing mortality rates due to cancer at both regional and global levels are driving the demand for advanced and innovative treatment practices. According to GLOBOCAN's 2022 estimates, there were approximately 9.74 million cancer-related deaths and nearly 20 million new cancer cases diagnosed globally. The rising prevalence of cancer, coupled with the demand for adequate treatment plans to achieve better clinical outcomes, is expected to accelerate the growth of the market for treatment planning systems and advanced image processing.
North America treatment planning systems and advanced image processing market will reach USD 1.9 billion by 2032 due to the well-established healthcare infrastructure.
The oncology segment in the market generated USD 994.8 million in 2023 and is expected to grow at 8.8% CAGR during 2024-2032 owing to the ongoing innovations in imaging technologies.
The treatment planning systems and advanced image processing market size was valued at USD 2 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to the rising prevalence of cancer.
Accuray Incorporated, Agfa-Gevaert Group, Brainlab AG, Canon Medical Systems Corporation, C-RAD AB, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., IBA Radiopharma Solutions, IntraOp Medical Corporation, and Koninklijke Philips N.V among others